Back to Journal

SM Journal of Hematology & Oncology

Comparative Study between Automated and Manual Methods of Complete Blood Counting in Patients Using Intravenous Solutions

Abstract Citation INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION CONCLUSIONS DATA AVAILABILITY STATEMENT FUNDING STATEMENT CONFLICT OF INTEREST DISCLOSURE AUTHOR CONTRIBUTIONS ACKNOWLEDGMENT ETHICS OF APPROVAL STATEMENT REFERENCES
Details

Received: 13-Aug-2026

Accepted: 04-Sep-2026

Published: 05-Sep-2026

Mohammed AL-Dulaiei1-3*# and Bakeel A. Radman4,5#

1Department of Medical Laboratories, Thamar University, Yemen

2Department of Biology, Thamar University, Yemen

3Key Laboratory of Medical Laboratory Diagnostics of the Education Ministry, Chongqing Medical University, China

4Cancer Center, Southern Medical University, China

5Department of Biology, Albaydha University, Yemen

#These authors contributed equally to this work

Corresponding Author:

Mohammed AL-Dulaiei, Department of Medical Laboratories, Institute for Continuous Learning, Thamar University, Yemen

Keywords

CBC; Intravenous Solutions; Sysmex Kx-21; Medonic M32; Manual.

Abstract

Objective: This study examines the impact of diluting IV fluids on blood parameters using two automated haematology analyzers (Sysmex KX-21 and Medonic M32) alongside manual techniques, highlighting the importance of laboratory services in healthcare and medical diagnosis. Materials and Methods: Blood samples were collected before and after intravenous administration of solutions and sent to the laboratory for measurement of hematological parameters, including Hb, RBC count, WBC count, PCV, MCV, MCH, and MCHC. Additional samples were collected after administration of intravenous solutions. Results: Sysmex KX-21 showed higher hematocrit and mean corpuscular volume than manual methods and Medonic M32. However, both showed significantly lower mean corpuscular hemoglobin compared to manual measurements. Medonic M32 had an elevated mean corpuscular hemoglobin concentration. White blood cell counts were comparable between Sysmex KX-21 and manual methods, with Medonic M32 showing lower counts, though the difference was not statistically significant. Conclusion: Automated haematological analyzer readings are as reliable as the standard manual method. WBC count, RBC count, Hb, and Hct were the most commonly affected by intravenous solutions when automated haematology analyzers and manual methods were used to measure them. WBC, MCH, and MCHC were slightly affected by intravenous solutions. RBC and MCHC by the Medonic M32 automated haematology analyzer were slightly higher than those by the Sysmex KX-21 automated haematology analyzer and the manual method. HCT and MCV by the Sysmex KX-21 automated haematology analyzer were higher than those by the Medonic M32 automated haematology analyzer and the manual method.

Citation

AL-Dulaiei M, Radman BA, (2026) Comparative Study Between Automated and Manual Methods of Complete Blood Counting in Patients Using Intravenous Solutions. SM J Hematol Oncol 8(1): 1021.

INTRODUCTION

Laboratory services are crucial to the population’s health, as the hematology department plays a vital role in the laboratory. Furthermore, due to the need for proper clinical evaluation in Yemen, blood studies and analyses have proven to be among the most important tools in healthcare and medical diagnosis [1]. The Complete Blood Count (CBC) is the most commonly requested test in hematology laboratories, and numerous prior studies have demonstrated that it provides valuable insights into the pathophysiology of blood cells and the reticuloendothelial system. Age, gender, altitude above sea level, sample type, available technology, staff, and dynamic resources can all affect normal CBC levels across laboratories. Depending on the technology staff and financial resources available, the quantity and type of investigations vary greatly among laboratories. Hemoglobin (Hb), White Blood Cell (WBC) count, Red Blood Cell (RBC) Erythrocyte Volume (PCV), and platelet count are all included in CBC [2]. CBC analysis provides information on specific parameters associated with each type of blood cell, used to estimate the overall heal th state [3]. Many components of CBC can be identified using manual, semi automated, or automated procedures. Although many laboratories today use semi-automated and fully automated machinery, traditional manual methods remain vital, serving as reference methods for most automated applications. Clinicians occasionally order a manual CBC because they know the patient’s history, symptoms, and therapeutic drugs that may need to be evaluated to detect abnormal results that the tools alone may not reveal [4].

Manual approaches, although they have reasonable accuracy, have certain downsides in terms of errors that arise in different measurements. Incorrect mixture, incorrect anticoagulant, insufficient or prolonged mixing can all impact the measured and computed parameters of blood samples. Improper preparation and storage of hemoglobin estimation reagents, inaccurate addition of blood volume to the test reagent, and errors in red cell counts, including both technical and inherent errors, all impact the outcomes [5]. Technical errors include the use of inaccurate straws, poorly calibrated pipettes or counting chambers, insufficient red mixing of cell suspensions, incorrect filling of counting chambers, and careless counting of cells in the chamber. Inadequate mixing of excess anticoagulant blood, tubular lumen deviation, and reading difficulty can all lead to misleading PCV findings. All of these elements contribute to inaccurate blood test results and miscalculation errors. However, in the calculation of specific blood parameters, such as hemoglobin, there is a link between manual and automated procedures [6].

The majority of automated counters use a modified version of the manual cyanohemoglobin test. In specific counters, HICN has been replaced by a nontoxic chemical technique [7]. Furthermore, electronic cell counting technologies are available. In modern hospitals and clinics, manual CBCs have been replaced by automated blood analyzers, which, although reducing the number of medical technicians in medical laboratories, result in lower expenses [4]. Even though automated techniques incur costs, they ultimately lead to lower expenses. Although highly capitalized, it provided a high level of accuracy and achievability for what was once a difficult laboratory task. Because of their speed, they can process a large number of blood samples, and the quality of the results makes them suitable even for small laboratories with few technicians [6], despite their initial use in laboratories in the early 1960s. Counting instruments have advanced since then, but they are still relatively simple, high-tech analyzers that can count all three types of blood cells, calculate hemoglobin levels, and calculate red cell indices all at the same time, these tools’ analytical reach has recently been increased to include data on cell size variation With the help of automated techniques, erythrocyte derivation, PCV, and MCV are all linked [8]. The inaccuracy could be caused by chance, for example, when cells pass through an aperture one at a time and are counted as a single cell, or by a pulse created during the circuit’s electronic dead period, for example count bubbles, lipid droplets, bacteria, or extraneous particles as cells by recycling cells that have previously been counted by agglutinating red blood cells [6].

Because of blood loss and dilution from fluids administered to patients, Hb and Hct concentrations fall in patients who are bleeding, and changes in the quantities of WBCs, RBCs, and platelets, as well as in erythrocyte indices (MCV, MCH, and MCHC), are made to reduce Hct and Hb. Isotonic solutions, such as Normal Saline (NS), are currently the most popular Fluid resuscitation solutions in the emergency department [9]. While prior research has linked lower hemoglobin levels caused by NS infusion to a small number of patients, other studies have reported a higher number [10]. Despite this, there is rarely a link between automatic blood analyzers and manual technology.

Clinical laboratories are aware of the problem of differences in haematological parameter values between automated and manual methods. One important but often overlooked confounding factor is administering Intravenous (IV) fluids before taking a sample, which may dilute the sample and alter the results. Additionally, it is not standard practice in many places to record the timing of phlebotomy in relation to IV therapy, which could affect the accuracy of the results. This study aimed to investigate the effect of diluting IV fluids on a group of blood parameters. We performed a comparative examination of data from diluted and non-diluted blood samples using two automated haematology analysers (Sysmex KX-21 and Medonic M32) alongside standard manual techniques.

MATERIALS AND METHODS

Materials

Micropipette (Mettler Toledo, China), Capillary tube (Mettler Toledo, China), Tube (Mettler Toledo, China), Tips (yellow and blue) (Mettler Toledo, China), Chamber (hemocytometer)(Horsham, Germany), 1000 mL Drabkin reagent (Hb) (AGAPE, China), 500 mL Turk‘s solution(WBC) (AGAPE, China), 500 mL Normal saline (RBC) (Shijiazhuang, China), 500 mL Lysis (CBC) (Guangdong, China), 5 Liter Diluent (CBC) (Guangdong, China). Equipment used in this study: KX-21(Sysmex Corporation, Japan), Medonic M32 (German Spanish company, Germany), Spectrophotometer for Hb (Rayto RT-9200, Germany), Hematocrit Hct ( Jiangsu, China), Light microscope (Olympus, Philippines), Shaker (Biobase, China).

Study Design

This study is an experimental investigation designed to compare manual and automated CBC analysis, with a specific focus on Hb analysis and the total counts of WBC, RBC, and PCV, as well as MCV, MCH, and MCHC (Figure 1).

Figure 1: Study design

Study Population and Samples

Eleven adults visited the emergency departments of Taiba Consultation Hospital and the General Dhamar Hospital Authority. Those people needed an intravenous solution. Two types of blood samples were used: A Non-diluted sample (before using the intravenous solution) and a diluted sample (after using the intravenous solution 250 ml). They agreed to share in this study as volunteers.

Blood Samples Collection

Blood samples were of two types. The first type of sample was a Non-diluted sample (before using the intravenous solution). 5 mL of intravenous blood was collected using a new, disposable 5 mL syringe. Blood was placed in an EDTA tube and thoroughly mixed. The second sample was diluted (after use of any intravenous solution). Five milliliters of intravenous blood were taken using a new, disposable 5 ml syringe.

1. Hemoglobin

1.1. Cyanomet-Hemoglobin Method Principle

Whole blood is diluted in a solution containing Potassium Ferricyanide and Potassium Cyanide, Hemoglobin will be oxidized by the action of Potassium Ferricyanide to form Methemoglobin (Hemoglobin, Hi) Potassium Cyanide will provide Cyanide ions to form Cyanomethemoglobin (HiCN), This solution can be measured spectrophotometrically and compared to known hemoglobin standards or in filter colorimeter using a yellow green filter, This procedure is applicable in diagnosing and monitoring therapy in cases of hemoglobin deficiency anemia’s [11]. Hb+K3Fe(CN)6→Hi, Hi+KCN→HiCN.

1.2. Cyanmethemoglobin Procedures

Add 20 μL of blood to 4 mL of Drabkin’s solution (1:251 dilution). Put the stopper in the tube and invert it several times. Allow the sample to stand at room temperature for 5 minutes. Then, pour the sample into a cuvette. Read the Absorbance at 540 nm (yellow-green filter) in a spectrophotometer (Rayto RT-9200, Germany) against the reagent as blank 6. Hb (g/dL) = Absorbance of test sample X factor (37) or Extract the unknown hemoglobin concentration, using the following equation [12].

PCV (Packed Cell Volume)

1. Principle of PCV

Hematocrit is the ratio of the total volume of RBCs to that of whole blood, expressed as a percentage (%) (whole blood = total volume of cells + plasma). The second synonym for hematocrit is PCV (Packed Cell Volume). The procedure is easy to perform, Whole blood is centrifuged in a narrow tube (capillary tube), and cellular elements will be separated from the plasma, after centrifugation blood will be separated into three layers: The bottom layer contains packed RBCs, The Middle layer contains WBC’s and Platelets (on top of RBC’s), Upper plasma layer [13].

2. Procedures of PCV

Mix EDTA with blood. After adequate mixing, fill the self-sealing capillary tubes two-thirds to three-fourths full. Seal the tube with a plastic seal (such as a creased mini seal) or by heating the dry end of the tube rapidly in a fine flame (using the pilot light of a Bunsen burner). Centrifuge for 5 minutes at 12000 g, so that additional centrifugation does not pack the red blood cells more. Carefully locate the filled capillary in one of the numbered slots of the microhaematocrit rotor with the sealed end against the rim gasket (to prevent breakage). Write the slot number on the patient’s form. Position the inner lid carefully to avoid dislodging the tubes. Read the PCV using a special HCT reader. Express the results in percentage (%) [14].

RBC Count

1. Principle of RBC Count

A specified volume of blood is diluted with a specified volume of isotonic fluid. This isotonic diluting fluid will not lyse RBCs and will facilitate counting with a hemacytometer [15].

2. Procedures of RBC Count

Pipette 4.0 ml of diluting fluid into a tube. Pipette 20 μL of will mix anticoagulated whole blood into the tube. Let it stand for 2-3 minutes. Load the cleaned hemacytometer. Place the hemacytometer on the microscope stage, and lower the condenser. Focus with an x10 objective lens on the large central square. This square is divided into 25 small squares, each of which is further divided into 16 smaller squares. Of the 25 squares, only the four corner squares and one middle square are used to count RBCs. Switch to the 40x objective lens and start counting in the five designated squares. Diluting fluid-(1:200) Isotonic saline: 0.85% sodium chloride (NaCl) in distilled water (8.5 g of NaCl in 1ml of D.W). The diluted specimen (1:200) is stable for 6 hours [16]. Total RBC count = N x Dilution factor x volume correction factor, N the total number of red blood cells counted in the counting chamber, Dilution factor = 200 (since it is 1:200). Each counted square has a volume of 0.2 x 0.2 x 0.1 = 0.004, five squares’ volume = 5 x 0.004 = 0.02 cc. volume correction factor = 1/0.02 = 50. The value was calculated according to the references. Using the previous equation [17].

WBC Count

1. Principle of WBC Count

A sample of whole blood is mixed with a diluent, which lyses red blood cells and stains the nuclei of white blood cells. White blood cells are counted in a hemocytometer counting chamber under the microscope, and the result is expressed as the total number of leukocytes per microliter (μL) of blood or liter (L) of blood [18].

2. Procedures of WBC Count

Mix the blood sample with the anticoagulant gently but thoroughly, either by inversion, manual mixing, or mechanical rocking. Pipette 0.38 ml (380 μL) of diluting fluid into a 12x75 mm tube, Pipette 0.02 ml (20 μL) of well-mixed blood to be counted, wipe the tip with gauze into the tube containing diluting fluid, and mix the tube. Let the tube stand for 2-3 minutes to ensure complete RBC lysis, then mix well. Prepare the clean hemacytometer and cover it with the designed coverslip. Load one side of the hemacytometer using a capillary tube or micropipette, ensuring it is neither overloaded nor underloaded. Allow the hemacytometer to sit for several minutes, allowing the WBCs to settle in the counting chamber. To prevent drying, place the loaded hemacytometer in a covered Petri dish lined with moist gauze until counting. Place the hemacytometer on the microscope stage, Focus with a 10x objective lens (low power), and lower the condenser. The WBCs are counted in the four large corner squares, using a hand tally counter. Diluting Fluid: 2% Acetic Acid in distilled water (2 ml glacial acetic acid + 98 ml distilled water). Turk’s solution: Glacial acetic acid – 2 ml. Lyses RBCs. Gentian violet 1% w/v 2ml, 2ml stains the nucleus of WBCs. Distilled water – 98 ml [19]. The value was calculated according to the references, using the following equation 

RBC Indices MCV, MCH, and MCHC

Automated CBC Analysis

Used KX-21 Sysmex and Medonic M 32 instructions.

1. CBC Analysis (KX-21 Sysmex Corporation)

This device works by analyzing blood tests, which are typically taken in the following manner. Hb analysis, RBC count, WBC count, PCV, MCV, MCH, and MCHC. According to the following references [4].

2. CBC Analysis (Medonic M 32)

The device operates by analyzing blood tests, which are as follows. Hb analysis, RBC count, WBC count, PCV, MCV, MCH, and MCHC. According to the following references. (Boule Medical AB, Medonic M-series M32 system Service Manual BM850, No. 1504435 Version 03).

Statically Analysis Tests

The data among CBC analysis methods were analyzed by using one way analysis of variance (ANOVA). A comparison between non-diluted and diluted samples was analyzed using the t-test. The data was analyzed using SPSS 22 computer software. The significant difference between groups was accepted at p 0.05.

RESULTS

Comparison between Hematological Analysis Methods

Our results are presented in the following tables. Table 1 shows that WBC count in Sysmex KX-21 system was 6.35±2.97, whereas in the manual method, it was 6.22±3.24. In contrast, Medonic M32 analyzer yielded a decreased level of 5.90±3.22, with a non-significant difference. Additionally, the study found that RBC count in Sysmex KX-21 system was 4.64±0.839, in the manual method was 4.46±1.198, and in Medonic M32 system was 4.49±0.944, with no significant difference. HGB in the Sysmex KX-21 system recorded 12.76±2.072 as a value of mean ±SD and in the manual method mean ±SD was 12.40±2.306, but in the Medonic M32 system showed a low level of mean ±SD 11.72±2.237 with non significantly different, in addition to, Hct in Sysmex KX-21 system showed increase level 40.96±6.036 and in manual method recorded decrease level mean of ±SD 36.63±6.328 with significantly different P 0.025 compared with Sysmex KX-21 system, whereas in Medonic M32 system recorded decrease level 33.49±6.305 (Figure 2),(Table 1).

Figure 2: Comparison between Hct in hematological analysis methods of (non-diluted and diluted groups.

Table 1. Comparison Between Haematological Analysis Methods of (Non-Diluted and Diluted Groups)

CBC

Analyzers

Mean±SD

P . Value

 

 

WBC

Sysmex KX-21

6.35±2.97

 

Manual

6.22±3.24

 

Medonic M32

5.90±3.22

 

 

 

RBC

Sysmex KX-21

4.64±0.839

 

Manual

4.46±1.198

 

Medonic M32

4.49±0.944

 

 

 

HGB

Sysmex KX-21

12.76±2.072

 

Manual

12.40±2.306

 

Medonic M32

11.72±2.237

 

 

 

HCT

Sysmex KX-21

40.96±6.036

 

Manual

36.63±6.328

A=0.025

Medonic M32

33.49±6.305

 

 

 

 

MCV

Sysmex KX-21

89.39±9.769

A=0.002

Manual

85.72±18.802

 

 

Medonic M32

 

72.11±11.273

A=0.002 B=0.013

 

 

MCH

Sysmex KX-21

27.84±3.692

 

Manual

28.65±6.321

Medonic M32

26.29±3.340

B=0.001

 

 

MCHC

Sysmex KX-21

31.08±1.704

 

Manual

33.05±0.121

A=0.001

Medonic M32

35.04±1.139

A=0.001

 

A comparison between Sysmex KX-21 and Manual or Medonic M32.

B comparison between Manual and Medonic M32.

Statically analysis showed that MCV in the Sysmex KX-21 analyzer appeared a high size of RBC 89.39±9.769 with a significantly different 0.002 compared with the manual method and Medonic M32 system, also manual method recorded a low size of RBV, but it was very low size 72.11±11.273 in Medonic M32 analyzer with P 0.002 compared with Sysmex KX-21 analyzer and with P 0.013 compared with manual method (Figure 3). MCH analysis showed 27.84±3.69 on Sysmex KX-21 analyzer. It was a decreased level of about 28.65±6.321 in the manual method, whereas, in Medonic M32 analyzer, it was a decreased level of about 26.29±3.340 with P 0.001 compared with the manual method (Figure 4), also in Table 1, MCHC in Medonic M32 analyzer showed an increased level of mean ±SD 35.04±1.139 with a significantly different 0.001 compared with Sysmex KX-21 analyzer and Medonic M32 analyzer. However, in the manual method, the level was also increased by about 33.05±0.121, with P=0.001, compared with Sysmex KX-21 and the manual method. In contrast, the lowest mean ± SD was 31.08 ± 1.704 in Sysmex KX-21(Figure 5).

Figure 3: Comparison between MCV in hematological analysis methods of (non-diluted and diluted groups.

Figure 4: Comparison between MCH in hematological analysis methods of (non-diluted and diluted groups.

Figure 5: Comparison between MCH in hematological analysis methods of (non-diluted and diluted groups.

Comparison of Hematological CBC Parameters between Non-Diluted and Diluted Groups:

Statistical analysis in Table 2 showed that, in comparison between the -diluted group and diluted group, WBC recorded an increased level of 6.86±2.97 in the - diluted group. However, it showed a decreased level of about 5.85±3.03 in the diluted group, with a non-significant difference (Figure 6). Additionally, the mean RBC level ±SD was mainly 4.95±0.676 in the diluted group.

Table 2. Comparison Between Non-Diluted and Diluted

CBC

Group

Mean SD

P.Value

 

 

WBC

Non-Diluted

6.86±2.97

 

 

Diluted

 

5.85±3.03

 

 

RBC

Non-Diluted

4.95±0.676

 

 

A=0.082

 

Diluted

 

4.33±0.900

 

HGB

Non-Diluted

13.59±1.653

 

A=0.059

Diluted

11.93±2.186

 

HCT

Non-Diluted

43.63±4.814

 

A=0.035

Diluted

38.30±6.138

 

MCV

Non-Diluted

88.93±9.690

 

Diluted

89.85±10.298

 

 

MCH

Non-Diluted

27.77±3.871

 

Diluted

27.91±3.691

 

 

MCHC

Non-Diluted

31.12±1.327

 

Diluted

31.04±2.082

 

 

 

PLT

Non-Diluted

237.72±85.798

 

 

Diluted

 

200.36±92.789

 

 

A comparison between Sysmex KX-21 and Manual or Medonic M32.

B comparison between Manual and Medonic M32

The mean ±SD RBC level was approximately 4.33±0.900 in the diluted group, with a P value of 0.082 by Sysmex KX-21 analyzer compared with the manual method and Medonic M32 analyzer (Figure 7). In the non-diluent group, HGB recorded a 13.59±1.653 increase level, which was significantly different from the 0.059 level measured by Sysmex KX-21 analyzer compared with the manual method and Medonic M32 analyzer. However, the decreased level in the diluted group was 11.93±2.186 (Figure 8).

Figure 6: Comparison between WBC in the hematological analysis of (non-diluted and diluted groups

Figure 7: Comparison between RBC in the hematological analysis of (non-diluted and diluted groups.

Figure 8: Comparison between HGB in the hematological analysis of (non-diluted and diluted groups

Additionally, Hct showed a high mean ± SD level of 43.63 ± 4.814 in the non-diluted group, with a P value of 0.035 by Sysmex KX-21 analyzer compared with the manual method and Medonic M32 analyzer. Conversely, it was 38.30 ± 6.138 at a low level mean ± SD in the diluent group. MCV mean ± SD was a convergent value, which was 88.93 ± 9.690 in the diluent group and 89.85 ± 10.298 in the diluent group. In the non-diluent group, MCH showed a mean ±SD of 27.77±3.871 and 27.91±3.691 in the diluent group, with non-significantly different results. In addition, MCHC in the non-diluent group was 31.12±1.327, and in the diluent group, it was 31.04±2.082, with significantly different results. In the diluent group, platelets showed a 237.72±85.798 increase in level, with no significant difference compared to the manual method and Medonic M32 analyzer using Sysmex KX-21 analyzer. However, it was a 200.36±92.789 decrease level in the diluted groups.

Comparison of Hematological CBC Analysis between Methods in Diluted Groups

Laboratory analysis in Table 3 recorded a comparison between methods. In diluted groups, WBC count using the manual method showed a high level of 6.22±3.328. However, the values were 5.90±3.223 and 5.85±3.037 using Medonic M32 analyzer. Sysmex KX-21 analyzer showed non-significantly different results. Additionally, RBC count was recorded as 4.33±0.90 using Sysmex KX-21 analyzer, 4.46±1.23 with the manual method, and 4.49±0.94 with Medonic M32 analyzer, with no significant differences. In the manual method, HGB recorded 12.40±2.363 mean ±SD, which is high compared with mean ±SD by Sysmex KX-21 analyzer and Medonic M32 analyzer, which are 11.93±2.186 and 11.72±2.237,consecutively, with non-significantly different means, also a high level mean ±SD 38.30±6.138 of HCT by Sysmex KX-21 analyzer, which is in contrast to the mean ±SD level by Medonic M32 analyzer, which is 33.49±6.305. In contrast, the increase is more pronounced than the mean ± SD by the manual method, which is 36.63 ± 6.484, and this difference is significant (p = 0.084) compared with the manual method and Medonic M32 analyzer.

Table 3. Comparison Between Methods in Diluted

CBC

Methods

Mean SD

P . Value

 

WBC

Sysmex KX-21

5.85±3.037

 

Manual

6.22±3.328

Medonic M32

5.90±3.223

 

RBC

Sysmex KX-21

4.33±0.900

 

Manual

4.46±1.227

Medonic M32

4.49±0.944

 

HGB

Sysmex KX-21

11.93±2.186

 

Manual

12.40±2.363

Medonic M32

11.72±2.237

 

HCT

Sysmex KX-21

38.30±6.138

A=0.084

Manual

36.63±6.484

Medonic M32

33.49±6.305

 

MCV

Sysmex KX-21

89.85±10.298

A=0.006

Manual

85.72±19.267

B=0.032

Medonic M32

72.11±11.273

 

MCH

Sysmex KX-21

27.91±3.691

 

Manual

28.65±6.477

Medonic M32

26.29±3.340

 

MCHC

Sysmex KX-21

31.04±2.082

 

Manual

33.05±0.121

Medonic M32

35.04±1.139

MCV showed an increased size mean ±SD 89.85±10.298 in Sysmex KX-21 analyzer with a significantly different 0.006 compared with the manual method and Medonic M32 analyzer, decrease size mean ±SD 85.72±19.267 in the manual method with different P 0.032 compared with Medonic M32 analyzer and immensely decrease size mean ±SD 72.11±11.273 in Medonic M32 analyzer, in addition to MCH recorded high level mean ±SD 28.65±6.477 in manual method, slightly low level compared with manual mean ±SD 27.91±3.691 by Sysmex KX-21 analyzer and low level mean ±SD 26.29±3.340 in Medonic M32 analyzer without significantly, finally MCH showed high level mean ±SD 35.04±1.139 in Medonic M32 analyzer. In contrast, it recorded a low mean ± SD of 31.04 ± 2.082, with a non-significant difference, as measured by Sysmex KX-21 analyzer.

DISCUSSION

This study, conducted in Dhamar City, Yemen, in 2022, aimed to compare hematological parameters using two automated hematological analyzers, Sysmex KX-21 and Medonic M32, with the manual method in patients receiving venous solutions. The present study was done on 11 patients using intravenous solutions. Our results showed that Hb values in the methods of non-diluted and diluted groups by using Sysmex KX-21, Medonic M32 automated hematology analyzer, and manual method were the same with non -significantly different, which agreed with the study done in Iran which found that there was only significantly different P 0.01 between the value of hemoglobin in the sample per 60 patients [21].

Hct in manual and Medonic M32 automated hematology analyzer showed a decreased level compared to Sysmex -KX-21 automated hematology analyzer which showed an increase with a significant relationship at a significant level of P < 0.025 and this study agreed with the study done in Sudan which found that there were strongly significantly different P 0.025 per 50 patients [22], and disagreed with a study done in Sudan found Hct decreased with significant difference of P < 0.0011[6]. The current study revealed that there was no significant difference between RBC count in Sysmex KX-21, Medonic M32 automated hematology analyzers, and the manual method which strongly agreed with a study done in Italy by which found that RBC count was decreased with a significant difference with P 0.001 per 30 patients by using Sysmex KX- 21 automated hematology analyzer and manual method [23]. The results showed that WBC counts in Medonic M32 automated hematology analyzer were decreased when compared to Sysmex KX-21 automated hematology analyzer and manual method, with no significant difference, and this agreed with a study done in Turkey that found that WBC count decreased without a significant difference using Beckman Coulter LH 780 hematology autoanalyzer for 29 patients [24]. This study revealed a strongly significant difference at a significant level of P 0.002 between MCV in Sysmex KX-21 compared with Medonic M32 and manual method, P 0.002 in Medonic M32 compared with Sysmex KX-21 and P 0.013 compared with the manual method and this agreed with a study that done in Sudan that found that MCV decreased with significant P 0.002 per 438 cases using Sysmex KX-21 automated hematology analyzer [25].

The current study found a significant relationship at a p-value of 0.001 between MCH in Medonic M32 and the manual method. It was nearly similar to the study conducted in Sudan by Awad et al. (2019), who reported significant differences in MCH with P value of 0.001 per 438 cases using Sysmex KX-21 automated hematology analyzer. In Medonic M32, MCHC showed an increased level, with a significantly different P value of 0.001 compared with Sysmex KX-21 automated hematology analyzer. In the manual method, the increase was statistically significant at a different P value of 0.001 compared to Sysmex KX-21 automated hematology analyzer, which is in strong agreement with a study conducted in India that found an increase in MCHC with P value of 0.000 per 30 cases [26].

The present study recorded Hb with a significant level of P = 0.059 in the non-diluted group using Sysmex KX-21 automated hematology analyzer compared with the manual method and Medonic M32 automated hematology analyzer; however, the level was decreased in the diluted group. In addition, Hct showed a high level in non -the diluted group with a different P 0.035 by Sysmex KX -21 automated hematology analyzer compared with the manual method and Medonic M32 automated hematology analyzer, whereas it was a low level in the diluent group with the same results by Sysmex KX- XP 300 [25] and this disagreed with Hct levels decreased with difference was statistically significant P < 0.005 [26]. The current study showed a high RBC level in the diluted group and a low RBC level in the diluted group, with different P 0.082 by Sysmex KX 21 automated hematology analyzer compared with the manual method and Medonic M32 automated hematology analyzer, and this is similar to a study that was done in Indonesia, which found RBC count without significant difference [27]. WBC level increased in the non-diluted group. However, it showed a decreased level in the diluted group, with no significant difference between pre-saline replacement and post-saline replacement, as measured using a Beckman Coulter LH-780 hematology autoanalyzer in 29 patients [24].

MCV, MCH, and MCHC had similar values in both the non-diluent and diluent groups, with no significant differences. This finding agrees with a study conducted in Indonesia, which found no significant differences [10]. The present study recorded that Hb in diluted groups was high compared with Sysmex KX-21 and Medonic M32 automated hematology analyzers, with non-significantly different levels, also a high level of HCT by Sysmex KX-21 automated hematology analyzer, which is increased compared with Medonic M32 automated hematology analyzer and manual method, with significantly different P 0.084, and this disagreed with any previous studies.

Our study revealed no significant difference in RBC count in Sysmex KX-21, Medonic M32 automated hematology analyzers, and the manual method. However, WBC count was decreased in Sysmex-KX-21 and Medonic M32 automated hematology analyzers compared with a manual method, with a non-significant difference, and this agreed with a study done by Ike et al. (2010), who found that RBC and WBC count showed a significant difference by Sysmex KX-21 automated hematology analyzer and manual method. This study demonstrated an increase in MCV using Sysmex KX-21 automated hematology analyzer, with a significantly different result of 0.006 compared to the manual method and Medonic M32 automated hematology analyzer. However, in the manual method, it was decreased by a different amount, P = 0.032, compared with Medonic M32 automated hematology analyzer. MCH recorded a high level in the manual method. However, the level was slightly lower compared to the manual method and Sysmex KX-21 automated hematology analyzer, as well as Medonic M32 automated hematology analyzer, without a significant difference. Finally, MCH showed a high level in Medonic M32 automated hematology analyzer. In contrast, it recorded a low level on Sysmex KX-21 automated hematology analyzer, with non-significantly different results [4].

CONCLUSIONS

The results of the present study confirmed that automated hematology analyzer readings are as reliable as those obtained using the standard manual method. WBC count, RBC count, Hb, and Hct are the most common tests that are affected by intravenous solutions when automated hematology analyzers and the manual method are used to measure them. WBC, MCH, and MCHC were slightly affected by the intravenous solutions and were slightly higher with the manual method than with Sysmex KX 21 and Medonic M32 automated hematology analyzers. RBC and MCHC values obtained using Medonic M32 automated hematology analyzer are slightly higher than those obtained with Sysmex KX-21 automated hematology analyzer and the manual method. Hct and MCV values obtained using Sysmex KX-21 automated hematology analyzer are higher than those obtained using Medonic M32 automated hematology analyzer and the manual method.

DATA AVAILABILITY STATEMENT

The data that support the findings of this study are available from the corresponding author upon reasonable request.

FUNDING STATEMENT

The authors received no specific funding for this work.

CONFLICT OF INTEREST DISCLOSURE

The authors declare no conflicts of interest.

Clinical Trial Registration

There is no clinical trial registration number because it is not required in my country.

AUTHOR CONTRIBUTIONS

M. AL-Dulaiei. Concepted, designed the study, drafted the paper. B.A.R. acquired, analyzed, and interpreted the data. All authors critically reviewed the draft, approved the final version, and accepted accountability for all aspects of the work.

ACKNOWLEDGMENT

The authors would like to thank Dr. Abdullah AL-Alawi for his support.

ETHICS OF APPROVAL STATEMENT

Thamar University Institute for Continuing Education deanship granted ethical approval (decision no: 317, decision date: 2022-03-15) in addition to human resources in healthcare institutions.

SUBJECT CONSENT

Patients or their family members gave their verbal informed permission after being fully informed about the goals and methods of the study. Prior to data collection, consent was renewed and participation was optional. All information gathered was anonymised and utilized exclusively for study.

REFERENCES

1. Heikali D and di Carlo D. A Niche for Microfluidics in Portable Hematology Analyzers. JALA: Journal of the Association for Laboratory Automation, 2010; 15: 319328.

2. Zandecki M, Genevieve F, Gerard J, Godon A. Spurious counts and spurious results on haematology analysers: A review. Part II: White blood cells, red blood cells, haemoglobin, red cell indices and reticulocytes. Int J Lab Hematol. 2007; 29: 21-41.

3. International Council for Standardization in Haematology, Writing Group; Briggs C, Culp N, Davis B, d’Onofrio G, Zini G, Machin SJ; International Council for Standardization of Haematology. ICSH guidelines for the evaluation of blood cell analysers including those used for differential leucocyte and reticulocyte counting. Int J Lab Hematol. 2014; 36: 613-627.

4. Ike SO, Nubila T, Ukaejiofo EO, Nubila IN, Shu EN, Ezema I. Comparison of haematological parameters determined by the Sysmex KX - 2IN automated haematology analyzer and the manual counts. BMC Clin Pathol. 2010; 10: 3.

5. HarsimranKaur VN, Selhi PK, Sood N, Singh A. Preanalytical Errors in Hematology Laboratory- an Avoidable Incompetence. Iran J Pathol. 2016; 11: 151-154.

6. ElSideeg, T. E. Comparison between manual semi-semi-manual electronic techniques (Doctoral dissertation, University of Khartoum). 2014.

7. Srivastava T, Negandhi H, Neogi, SB, Sharma J and Saxena R. Methods for hemoglobin estimation: A review of “what works”. J Hematol Transfus, 2014; 2: 1028.

8. Buttarello M, Plebani M. Automated blood cell counts: State of the art. Am J Clin Pathol. 2008; 130: 104-116.

9. Perel P, Roberts I, Ker K. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev. 2013; CD000567.

10. Gokcen E, Cevik Y, Pamukcu Gunaydin G, Dogan NO and Tekin M. Change in complete blood count parameters and vital signs after intravenous infusion of 1 liter of normal saline. Eurasian Journal of Emergency Medicine, 2018; 17: 71-74.

11. Jannah, K. The effect of jogging exercise is to improve hemoglobin levels. In Journal of Physics: Conference Series. IOP Publishing 2020; 1481: 012028.

12. Bhaskaram P, Balakrishna N, Radhakrishna KV, Krishnaswamy K. Validation of hemoglobin estimation using Hemocue. Indian J Pediatr. 2003; 70: 25-28.

13. Wong S, Di Girolamo N. Agreement between hematocrits measured with electrical conductivity on the i-STAT analyzer and manual packed cell volume measurements in 148 chelonian patients. Vet Clin Pathol. 2021; 50: 342-347.

14. Sheet SSM, Jarjees MS. Microcontroller-based in vitro hematocrit measurement system. Indonesian Journal of Electrical Engineering and Computer Science (IJEECS), 2020; 18: 717-723.

15. Lazaro JB, Cruz JD. Morphological Image Processing and Blob Analysis for Red Blood Corpuscles Segmentation and Counting. In 10th International Conference on Humanoid, Nanotechnology, Information Technology, Communication and Control, Environment and Management, Baguio City, Philippines. 2018.‏

16. Gautam A, Donohue D, Hoke A, Miller SA, Srinivasan S, Sowe B, et al. Investigating gene expression profiles of whole blood and peripheral blood mononuclear cells using multiple collection and processing methods. PloS one, 2019; 14: e0225137.

17. Zhang M, Gu L, Zheng P, Chen Z, Dou X, Qin Q, et al. Improvement of cell counting method for Neubauer counting chamber. J Clin Lab Anal. 2020; 34: e23024.

18. Estridge BH, Reynolds AP. Basic Clinical Laboratory Techniques (6th ed.). Cengage Learning. 2011.

19. Carisch L, Stirn M, Hatt JM, Federer K, Hofmann-Lehmann R, Riond B. White blood cell count in birds: Evaluation of a commercially available method. BMC Vet Res. 2019; 15: 93.

20. Greer JP, Arber DA, Glader B, List AF, Means RT, Paraskevas F, et al. Wintrobe’s clinical hematology. Lippincott Williams and Wilkins. 2013.

21. Yazdankhahfard MR, Taghizadeganzadeh M, Farzaneh MR, Mirzaei K. Comparison of complete blood count of blood samples taken through venipuncture and through the peripheral venous infusion line after the administration of fluids. Pars Journal of Medical Sciences, 2015; 12: 31-35.‏

22. Nassir HSAA. Comparison of Complete Blood Count Using Digon Dcell60, Sysmex kxn-21, and URIT 3010 Haematological Analyzers (Doctoral dissertation, Sudan University of Science and Technology). 2017.

23. Langer T, Ferrari M, Zazzeron L, Gattinoni L, Caironi P. Effects of intravenous solutions on acid-base equilibrium: From crystalloids to colloids and blood components. Anaesthesiol Intensive Ther. 2014; 46: 350-360.

24. Hatice BY, Huseyin Y, Mustafa OA. Normal Saline 0.9% replacement as a practical solution to matrix interference effect when a leukocyte differential count cannot be measured in chemotherapy patient samples. Trabzon, Turkey, 2021; 4: 161-165.

25. Awad KM, Bashir AA, Osman AA, Malek MA, Alborai AA, Ali IA, et al. Reference values for hemoglobin and red blood cell indices in Sudanese in Khartoum State. International Journal of Health Sciences and Research, 2019; 9: 210-214.‏

26.  Meintker L, Ringwald J, Rauh M, Krause SW. Comparison of automated differential blood cell counts from Abbott Sapphire, Siemens Advia 120, Beckman Coulter DxH 800, and Sysmex XE-2100 in normal and pathologic samples. Am J Clin Pathol. 2013; 139: 641-650.

27. Naim N, Kalma A, Hartono R, Yulianingsih A. Comparison of the results of counting the number of blood cells in the veins and capillary blood samples using medonic hematology equipment M-32 Series. NVEO-NATURAL VOLATILES and ESSENTIAL OILS Journal| NVEO, 2022; 823-836.

Citation

AL-Dulaiei M, Radman BA, (2026) Comparative Study Between
Automated and Manual Methods of Complete Blood Counting in Patients
Using Intravenous Solutions. SM J Hematol Oncol 8(1): 1021.

Other Articles

Article Image 1

High Throughput siRNA Screen Identifies LRP8 as Druggable Metabolic Regulator in Triple-Negative Breast Cancer

Background: Triple-Negative Breast Cancers (TNBC) overexpress a large number of genes compared to other breast cancer subtypes and these genes represent potential therapeutic targets.

Methods: We identified genes overexpressed in TNBC compared in public gene expression data sets and performed an siRNA screen with 4 distinct constructs against each of 681 overexpressed genes in 18 breast cancer cell lines. The top tier hits were assessed in functional and mechanistic studies to validate their role in the growth and survival of TNBC cells in vitro and in vivo.

Results: Low density Lipoprotein Receptor-Related Protein 8 (LRP8) and Very Low-Density Lipoprotein Receptor (VLDLR) was the top two ranked hits based on 3 of 4 siRNAs showing, significant and preferential growth inhibition in TNBC cell lines. Apolipoprotein E isoform 4 (ApoE4), and to a lesser extent rellin, which are ligands of both LRP8 and VLDLR stimulated the growth of TNBC cells in vitro in a receptor-dependent manner. Suppression of LRP8 or VLDLR expression or exposure to a ligand inhibitor, RAP abolished this ligandinduced proliferation. Metabolic profiling (with GC/MS and LC/MSMS) and reverse phase protein arrays (n=230 antibodies/201 proteins) revealed that ApoE4 stimulation rescued TNBC cells from serum-starvation, induced up-regulation of genes involved in lipid biosynthesis and increased protein expression of genes involved in the MAPK/ERK and DNA repair pathways.

Conclusion: LRP8 is overexpressed in TNBC and promotes cell growth and survival under nutrient depleted conditions through stimulating lipid biosynthetic pathways. Inhibitors of LRP8/VLDLR signaling represent potential new therapeutic targets for TNBC.

Banu Arun¹, Soley Bayraktar¹, Christine Shiang⁴, Yuan Qi², Bailiang Wang¹, Angelica GB¹, Fraser SW³, Liem Phan⁵, Mong-Hong Lee⁵, Yun Wu³, Gabriel NH¹, Vikram W⁶ and Lajos P⁶*


Article Image 1

Is Warfarin Obsolete?

Warfarin, the vitamin K antagonist, was the only one oral anticoagulant available over the last six decades for clinical use. Recently, though there has been an introduction of Newer Oral Anti Coagulants (NOACs) such as dabigatron, rivaraxoban, apixaban and edoxaban. These NOACs have changed the landscape for prophylaxis and treatment of Venous Thrombo Embolism (VTE) and non valvular atrial fibrillation

Visweshwar N¹*, Malachowski S¹, Jaglal M² and Laber D²


Article Image 1

GSK-3? and its Unexpected Role in Immunity, Inflammation and Cancer

Glycogen Synthase Kinase-3β (GSK-3β) is a key component of a complex array of cellular processes. Several mechanisms are involved in controlling its activity, including phosphorylation, protein complex formation and sub cellular distribution. Aberrant GSK-3β action has been implicated in many diseases and disorders, such as cancer, heart disease, metabolic and neurological disorders. More recently, GSK-3β has been identified as a crucial regulator of the balance between pro and anti-inflammatory cytokine production. This review will highlight the immunological importance of GSK-3β and the latest discoveries that led to the identification of a new central role of GSK-3β in tumor immunity.

Serena De Matteis¹, Roberta Napolitano¹ and Silvia Carloni¹*


Article Image 1

H.pylori Infection as Risk Factor for GIT Bleeding in Haemophilic Patients

Background: Helicobacter pylori is endemic in Egypt and present a main cause of gastrointestinal bleeding.

Aim: this study is to evaluate the prevalence of H.pylori infection in hemophilic patients, and to assess its impact on gastrointestinal bleeding associated with this infection in such patients.

Methods: we prospectively investigated the prevalence of H.pylori infection in 40 Egyptian patients with Hemophilia -A, -B and VonWillebrand syndrome and 20 normal male subjects was included. Every patient and control subject in the study was tested one time for H.pylori stool antigen by ELISA. All patients and control subjects were tested for occult blood using Guaiac-based fecal occult blood test. Results: Twenty eight out of 40 patients (70%) are H. pylori positive; and 12 out of 20 controls (60%) are H. pylori positive. The odds ratio is ‎1.55, 95% CI (0.6162 to 3.9269), ‎Significance level P=0.3497. Among 28 H.pylori positive patients, 5 patients (17.9 %) tested positive for occult blood. Among the 12 H.pylori positive subjects ‎ in the‎ control group, only one tested positive for occult blood (8.3%). Odds ratio for Occult bleeding in H pylori positive patients and control was 2.39: P=0.4504. None of the H.pylori negative patients or control subjects had a positive occult blood disease. Conclusion: patients with hemophilia, H. pylori should not be considered as an important cause of GI bleeding. The recurrence of the infection and GI bleeding could be prevented with eradication of H.pylori. Screening tests for H. pylori would not be needed in patients with hemophilia in endemic areas.

Noha M. El Husseiny¹*, Louis Essac and Mona Al Kassas


Article Image 1

Evaluation of CD 25 (IL2 Receptor Alpha) Expression in Adult Acute Lymphoblastic Leukemia Patients

Background: Many parameters are included to determine the risk stratification of Acute Lymphoblastic Leukemia (ALL), Philadelphia Chromosome (Ph)/BCR-ABL–positive (ALL) is the largest genetically defined subtype in adult ALL with poor outcome. Here, we detected IL-2Rα (CD25) in patients with ALL and explored its diagnostic and prognostic value.

Patients and methods : Thirty ALL patients were recruited in Egypt , newly diagnosed with ages above 18 years old, after informed consent they invited to perform CD25 marker using Coulter EPICSXL, PCR for BCR – ABL fusion gene and Fluorescence in Situ Hybridization (FISH) were also performed along with CBC, LDH, Uric acid, CT scan allover and testicular ultrasonography.

Results: (70%) of patients were males while (30%) were females with no statistically significant difference as correlated with CD25, 13 (43. 33%) patients had positive CD25 , recurrent infections had occurred in 8 patients (26. 67%) with no significant correlation with CD25 (P = 0. 361), 16(53. 33%) patients suffered from fever, while 5 (16. 67%) experienced bleeding with no significant correlation among them with CD 25 (P> 0.05 in both). FISH cytology and PCR were positive in 11 (36.67%) patients. There was highly statistically significant correlation among CD25 and FISH and PCR for BCR-ABL, LDH, total leucocytic count with (P value <0.001). We showed that CD25 measurements compare favorably with other ALL prognostic criteria.

Conclusion: (CD25) expression was corresponding to Philadelphia chromosome. IL-2R α (CD25) is proved to be a valuable marker for monitoring ALL patients, an important parameter for prognosis and follow-up of ALL patients

Inas Ahmed Asfour¹, Gihan Mohamed Kamal Shams El Din¹, Rasha Magdy Mohammed Said¹* and Entessar Mabrook Juadam²


Article Image 1

Hemophagocytic Lymphohistiocytosis, A Syndrome of Excessive Immune Activation: Review of the Literature

Hemophagocytic Lymphohistiocytosis (HLH) is a rare and life threatening syndrome caused by excessive and dis-regulated immune activation. It can present as a primary sporadic disorder or be secondary to a trigger disrupting the immune homeostasis, such as auto-immune disorders, malignancies and mainly infections. It is usually of low suspicion index, and has variable presentations lacking specific pathognomonic clinical or laboratory signs. HLH is a medical emergency, and is associated with poor prognosis in most of the cases. An early diagnosis and initiation of appropriate treatment may change the outcome. Here I present a review of the literature concerning HLH, and one related pathologically similar disorder, the Macrophage Activation Syndrome (MAS), emphasizing on the clinical presentation, associated etiologies, diagnosis, treatment and prognosis, thus making the clinicians more aware of this fatal syndrome in order to decrease the related mortality.

Georges EI Hachem¹*


Article Image 1

Osteosarcoma of the Distal Tibia

Osteosarcoma more frequently occurs in children and adolescents, at the position of knee-joint and proximal humerus.

Yufeng Chen¹*


Article Image 1

Clinical and Laboratory Analysis of Patients with Multiple Myeloma: Five-Year Experience

Background: Multiple myeloma (MM) is characterized by clonal expansion of plasma cell in the bone marrow and production of monoclonal immunoglobulin, with bone destruction, renal failure and suppression of the normal hematopoiesis. Identification of clinical factors and laboratory diagnosis is important to characterize the stage of the disease and estimate survival.

Objective: To identify clinical and laboratory diagnosis of patients with multiple myeloma treated at HEMOPE - Foundation of Hematology and Hematology of Pernambuco.

Methods: This was an observational, transversal study with secondary data obtained from medical records. A descriptive analysis of clinical and laboratory features and prognostic factors of 112 patients diagnosed with multiple myeloma was conducted from January 2010 to December 2014.

Results: The median age was 65 years, of these 49.1% were male and 50.9% female. The most common clinical manifestations were: bone pain (70.5%), weight loss (25%) and weakness (23.2%). Anemia has been observed at diagnosis in 75% of patients and hypercalcemia in 15.2%. Regarding the staging system at diagnosis, 94 (83.9%) patients were classified as stage III Durie-Salmon and 32 (28.6%) patients in stage II of the International Staging System (ISS).

Conclusion: Our found in this study were similar to previous reported in the literature. A good characterization of the patient’s diagnosis and the use of accurate diagnostic methods are the ideal approach for better risk classification, therapeutic choice and follow-up of patients with MM.

Duarte BP¹˒², De Souza Junior VR¹˒³*, Assis RA²˒⁴, Barros Correia CW¹˒², Hazin MF¹˒²˒⁴, and Correia MCB¹˒²


Article Image 1

Cauda Equina Involvement in Newly Diagnosed Myeloma Patient

Cauda Equina Syndrome (CES) is a rare complication of Multiple Myeloma (MM) that is a clonal plasma cell disorders. We presented a case who newly diagnosed MM which complicated with cauda equina involvement. A 51-year-old woman admitted to our hospital because of weakness and low back pain. Neurological examination demonstrated sphincter dysfunction, decreased Achilles tendon reflexes, frust hemiparesia, reflected CES. Laboratory analysis was revealed anemia, hipergammaglobulinemia and monoclonal peak in the protein electrophoresis. Magnetic resonance imaging (MRI) of the spine showed multiple vertebral compression fractures and marked contrast enhancement of the cauda equina region. The patient was diagnosed MM with bone marrow biopsy. After VAD treatment, MRI showed disappearance of infiltration. Although, there are some case reports with cauda equina involvement in myeloma patient, we could not find any case presenting with CES in newly diagnosed MM. This rare complication should be remembered in myeloma patients who presented symptoms of CES.

Demet Cekdemir¹˒²*, Nur Soyer¹, Halil Gulluoglu³, Gulgun Yilmaz Ovali⁴, and Mahmut Tobu¹


Article Image 1

Stem Cell Transplant for Multiple Myeloma: A Single Center Experience from Northern India

Autologous Stem Cell Transplantation (ASCT) is the preferred treatment for the management of multiple myeloma after initial 4-6 months of induction treatment.

Sanjeev Kumar Sharma*, Dharma Choudhary, Meet Kumar, Vipin Khandelwal, Divya Doval, Anil Handoo, Rasika Setia, and Tina Dadu